Shree Richa, Kedia Monica Ritu, Toshi Toshi, Raj Nikhil, Anand Kumar, Shahi Niharika
Department of Orthodontics and Dentofacial Orthopaedics, Buddha Institute of Dental Sciences and Hospital, Patna, IND.
Department of Periodontics, Buddha Institute of Dental Sciences and Hospital, Patna, IND.
Cureus. 2022 Dec 14;14(12):e32510. doi: 10.7759/cureus.32510. eCollection 2022 Dec.
Many dentists use articaine as their choice of local anesthetic agent. However, the use of articaine is limited to inferior alveolar nerve blocks (IANBs), and literature data are scarce concerning its perception and choice among various dental practitioners. The aim of the present study was to assess the extent of articaine use as a local anesthetic in dentistry, its perception basis, and the consistency of evidence of the efficacy and safety of articaine in recent practice. The present study utilized a survey tool that was given to all the participating dental practitioners, and the participants were given five minutes to fill out the survey questionnaire. The questionnaire was in English and had 14 questions to be answered. The data gathered were statistically assessed to formulate the results. The results of this cross-sectional survey reported that articaine is used as a choice of local anesthetic by more than half of the participating dental practitioners. Sixty percent (n = 480) participants used articaine in their practice, followed by lidocaine, which was used by 33% (n = 264) dental practitioners, mepivacaine by 2% (n = 16) participants, prilocaine by 1% (n = 8) dental practitioners, and other local anesthetics by 4% (n = 32) participants, respectively. Concerning the safety and efficacy of articaine use, 43% used it for all procedures except for IANBs, whereas 20% used it for all procedures, including IANBs. Despite the reported efficacy and safety of articaine as a local anesthetic for all dental procedures, many dental practitioners refrain from using it, especially for IANBs. These data depict a difference between current research evidence and reported clinical practice.
许多牙医选择阿替卡因作为局部麻醉剂。然而，阿替卡因的使用仅限于下牙槽神经阻滞（IANB），关于其在不同牙科从业者中的认知和选择的文献资料较少。本研究的目的是评估阿替卡因在牙科中作为局部麻醉剂的使用程度、其认知基础以及近期实践中阿替卡因疗效和安全性证据的一致性。本研究使用了一种调查工具，分发给所有参与的牙科从业者，参与者有五分钟时间填写调查问卷。问卷用英文编写，有14个问题需要回答。对收集到的数据进行统计评估以得出结果。这项横断面调查的结果报告称，超过一半的参与牙科从业者选择阿替卡因作为局部麻醉剂。60%（n = 480）的参与者在实践中使用阿替卡因，其次是利多卡因，33%（n = 264）的牙科从业者使用，2%（n = 16）的参与者使用甲哌卡因，1%（n = 8）的牙科从业者使用丙胺卡因，4%（n = 32）的参与者使用其他局部麻醉剂。关于阿替卡因使用的安全性和有效性，43%的人将其用于除IANB之外的所有手术，而20%的人将其用于包括IANB在内的所有手术。尽管有报道称阿替卡因作为所有牙科手术的局部麻醉剂具有疗效和安全性，但许多牙科从业者仍避免使用它，尤其是用于IANB。这些数据表明了当前研究证据与报告的临床实践之间的差异。
